Showing results (161-170 of 171) with videos related to

Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2026
Addition of Intravesical Recombinant BCG to Perioperative Chemo-Immunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase 2 Trial SAKK 06/19Richard Cathomas, Ulf Petrausch, Stefanie Hayoz, et al.
European Urology Oncology|November 5, 2024
Management of Small Testicular Masses: A Delphi Consensus StudyKarl H Pang, Giuseppe Fallara, João Lobo, et al.
BJU International|November 3, 2025
Local recurrence after glans-sparing surgery: no impact on penile cancer-specific survivalLaura Elst, Eduard Roussel, Marija Miletic, et al.
Trends in Plant Science|August 13, 2023
25 Years of thermomorphogenesis research: milestones and perspectivesMarcel Quint, Carolin Delker, Sureshkumar Balasubramanian, et al.
Genome Biology|December 15, 2020
Convergent network effects along the axis of gene expression during prostate cancer progressionKonstantina Charmpi, Tiannan Guo, Qing Zhong, et al.
Life Science Alliance|December 5, 2023
Proteomic-based stratification of intermediate-risk prostate cancer patientsQing Zhong, Rui Sun, Adel T Aref, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2021
Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update ConsortiumSilke Gillessen, Nicolas Sauvé, Laurence Collette, et al.
European Journal of Cancer (Oxford, England : 1990)|April 2, 2024
Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update ConsortiumEmanuel Bührer, David D'Haese, Gedske Daugaard, et al.
World Journal of Urology|September 19, 2024
Follow-up strategies after trimodal treatment for muscle-invasive bladder cancer: a systematic reviewErnest Kaufmann, Stefanie Aeppli, Winfried Arnold, et al.
Pageof 18